ArticleJournal of thoracic disease2023
Osimertinib as first-line treatment for recurrent lung cancer patients with
Atsushi Osoegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleJournal of thoracic disease2023
Atsushi Osoegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.